Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough time attracting investment capital in 2024. Small- and mid-cap biotech ...

Grey market grows for cheap weight-loss drugs imported from China Some users try small doses of substances not yet approved ...